|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/095 | |
| C12N 1/00 |
| (11) | Number of the document | 2613805 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11764868.3 |
| Date of filing the European patent application | 2011-09-09 | |
| (97) | Date of publication of the European application | 2013-07-17 |
| (45) | Date of publication and mention of the grant of the patent | 2019-10-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2011/053957 |
| Date | 2011-09-09 |
| (87) | Number | WO 2012/032498 |
| Date | 2012-03-15 |
| (30) | Number | Date | Country code |
| 201161429673 P | 2011-01-04 | US | |
| 381859 P | 2010-09-10 | US |
| (72) |
SERRUTO, Davide, IT
PIZZA, Mariagrazia, IT
DELANY, Isabel, IT
|
| (73) |
GlaxoSmithKline Biologicals SA,
Rue de l`Institut 89, 1330 Rixensart,
BE
|
| (54) | MENINGOCOCCUS OVEREXPRESSING NADA AND/OR NHBA AND OUTER MEMBRANE VESICLES DERIVED THEREFROM |
| MENINGOCOCCUS OVEREXPRESSING NADA AND/OR NHBA AND OUTER MEMBRANE VESICLES DERIVED THEREFROM |